Effects of Hyperandrogenism in PCOS: A Review Analysis

Show other versions (1)

The endocrine condition known as Poly Cystic Ovary Syndrome (PCOS) is becoming more common in the local areas of Pakistan. Concerningly, the prevalence of PCOS among women who are fertile has been increasing. It plays a significant role in the worldwide population's infertility and subfertili...

Full description

Bibliographic Details
Published in:	Pakistan Journal of Medical Research
Main Author:	javeria khan
Format:	Article
Language:	English
Published:	Health Research Institute (HRI), National Institute of Health (NIH) 2024-10-01
Subjects:	Ovulation infertility hyperandrogenism hirsutism phenotype
Online Access:	https://pjmr.org.pk/index.php/pjmr/article/view/432

Similar Items

Effects of Hyperandrogenism in PCOS: A Review Analysis
by: javeria khan
Published: (2024-10-01)

Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
by: Sairish Ashraf, et al.
Published: (2019-11-01)

Clinico-pathological correlation in Indian women presenting with cutaneous features of hyperandrogenism: A cross-sectional study
by: Vikas Pathania, et al.
Published: (2020-01-01)

PCOS and Hyperprolactinemia: Conflicting Conditions or Comorbidities?
by: Alina V. Atalyan, et al.
Published: (2021-12-01)

Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden
by: Sofia Persson, et al.
Published: (2022-12-01)

The influence of obesity on hyperandrogenism and infertility in the female
by: M.T. van der Merwe
Published: (2003-04-01)

Effective treatment of skin and metabolic manifestations of hyperandrogenism: a comprehensive improvement of quality of life
by: V. E. Balan, et al.
Published: (2019-04-01)

Treatment and complications of PCOS in adolescents - what’s new in 2023?
by: Karolina Jakubowska-Kowal, et al.
Published: (2024-10-01)

Effect of magnesium supplementation in improving hyperandrogenism, hirsutism, and sleep quality in women with polycystic ovary syndrome: A randomized, placebo‐controlled clinical trial
by: Mahsa Gholizadeh‐Moghaddam, et al.
Published: (2023-01-01)

Increased Serum AMH in a Subgroup of Women with Idiopathic Hyperandrogenism: Do These Women Have PCOS?
by: Enrico Carmina, et al.
Published: (2025-08-01)

Hirsutism, Acne, and Hair Loss: Management of Hyperandrogenic Cutaneous Manifestations of Polycystic Ovary Syndrome
by: Cenk Yasa, et al.
Published: (2017-08-01)

Hirsutism, Normal Androgens and Diagnosis of PCOS
by: Poli Mara Spritzer, et al.
Published: (2022-08-01)

The Leydig Steroid Cell Tumor in a Postmenopausal Woman with Clinical and Biochemical Hyperandrogenism: A Case Report
by: Larisa V. Suturina, et al.
Published: (2022-07-01)

Population and Diagnostic Characteristics of Polycystic Ovary Syndrome and Hyperandrogenism
by: Crystal Clark Douglas, et al.
Published: (2024-04-01)

Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach
by: Giuseppe Giuffrida, et al.
Published: (2017-06-01)

hyperandrogenism in polycystic ovary syndrome
by: malka S. Al- saadi
Published: (2006-01-01)

SCLEROCYSTIC OVARIES: CURRENT APPROACHES TO THE PROBLEM
by: A. G. Solopova, et al.
Published: (2017-08-01)

Virilizing insulinoma
by: Dominika Kochan-Olszewska, et al.
Published: (2025-08-01)

The Contribution of New Areas to the Total Hirsutism Scores in Basrah Hirsute Women
by: Rudha Naser Hussein, et al.
Published: (2017-11-01)

Evaluación clínica del pelo corporal en una población de mujeres colombianas: determinación del punto de corte para el diagnóstico de hirsutismo
by: Xiomara Ríos, et al.
Published: (2013-09-01)

Prevalence and Clinical Management of Adrenal Tumour-Related Hyperandrogenism: A Narrative Review
by: Sanja Medenica, et al.
Published: (2024-03-01)

Polycystic ovary syndrome - 80 years of research and new directions in the study (literature review)
by: L. V. Damdinova, et al.
Published: (2016-09-01)

Hyperandrogenism-mediated YAP activation drives ovarian inflammation and pyroptosis in PCOS: implications for follicular dysfunction
by: Tianyue Xu, et al.
Published: (2025-07-01)

N6-methyladenosine demethylase FTO related to hyperandrogenism in PCOS via AKT pathway
by: Yuan-Xue Jing, et al.
Published: (2023-12-01)

Polycystic ovary syndrome: a dermatologic approach
by: Patrícia Moreira-Gomes, et al.
Published: (2024-07-01)

Significant association of hyperandrogenism and insulin resistance with the epigenetic alterations in PPARG1 gene in granulosa cells of PCOS females
by: Zahra Dashti, et al.
Published: (2025-06-01)

Declining muscle NAD+ in a hyperandrogenism PCOS mouse model: Possible role in metabolic dysregulation
by: Ali Aflatounian, et al.
Published: (2022-11-01)

Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations
by: Afrin Yasmin, et al.
Published: (2022-11-01)

Clinical, biochemical and hormone profile in hirsute vs nonhirsute patients with polycystic ovary syndrome
by: Iram Shabir, et al.
Published: (2020-07-01)

Letrozole and clomiphene versus letrozole alone for ovulation induction in women with PCOS: a systematic review and meta-analysis
by: Karine Eskandar, et al.
Published: (2025-05-01)

Altered bile acids profile is a risk factor for hyperandrogenism in lean women with PCOS: a case control study
by: Yuchen Zhu, et al.
Published: (2024-10-01)

DIAGNOSIS OF HYPERANDROGENISM: DIFFICULTY AND THE CONSEQUENCES
by: N. I. Volkova, et al.
Published: (2017-03-01)

Valproate-Induced Hyperandrogenism in Girls
by: J Gordon Millichap
Published: (1999-04-01)

ABILITY TO RESTORE REPRODUCTIVE SYSTEM IN PATHINTS WITH COMBINED FORM OF HYPERANDROGENISM
by: R. A. Saidova, et al.
Published: (2016-06-01)

Experience of Using Letrozole as a First-Line Ovulation Induction Agent in Polycystic Ovary Syndrome (PCOS)
by: Nupur Nandi *, Mahua Bhattacharya, Amit Tolasaria and Banasree Bhadra
Published: (2011-01-01)

Comparison of self-assessed and clinician-assessed hirsutism diagnosed according to the modified Ferriman-Gallwey scale among female outpatients in Brazil
by: Talita Fernanda Oliveira, et al.
Published: (2024-07-01)

Polycystic ovary syndrome and depression: A neurobiological and biochemical correlation
by: Rumi Gayen, et al.
Published: (2025-11-01)

Hyperandrogenism as a side effect of anticonvulsants
by: E. V. Tsallagova, et al.
Published: (2018-08-01)

Does body mass index have an effect on the prevalence of various symptoms of polycystic ovary syndrome and their associated risk factors?
by: Kaur Raminder, et al.
Published: (2021-06-01)

Polycystic Ovary Syndrome (PCOS): A risk factor for infertility
by: Zanita Ismajli
Published: (2024-03-01)